We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Ehealth: Second Life Impacts Diabetes Education & Self-Management (SLIDES)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01186965
Recruitment Status : Completed
First Posted : August 23, 2010
Last Update Posted : March 6, 2015
Information provided by (Responsible Party):
Duke University

Brief Summary:
The purpose of this study is to to develop and evaluate the feasibility, usability, and effect of participation in SLIDES (a virtual diabetes community in Second Life) for providing interactive diabetes education, support, and resources.

Condition or disease Intervention/treatment
Type 2 Diabetes Behavioral: eHealth program in the Virtual Environment (VE) platform Second Life

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Ehealth: Second Life Impacts Diabetes Education & Self-Management
Study Start Date : January 2011
Primary Completion Date : August 2012
Study Completion Date : August 2012

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Intervention Details:
    Behavioral: eHealth program in the Virtual Environment (VE) platform Second Life
    determine the feasibility and acceptability of an eHealth program that provides diabetes education and self-management support.
    Other Name: Second Life

Primary Outcome Measures :
  1. Perceived Usefulness [ Time Frame: 3 and 6 months ]
  2. Perceived Ease of Use [ Time Frame: 3 and 6 months ]
  3. Process data [ Time Frame: January 2011 through May 2012 ]

Secondary Outcome Measures :
  1. Demographics [ Time Frame: baseline ]
  2. Metabolic Indicators [ Time Frame: baseline, 3 months, 6 months ]
  3. Diabetes knowledge [ Time Frame: baseline, 3 months, 6 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   21 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • current Duke Endocrinology patient
  • are between 21 and 75 years old
  • are able to speak and read English
  • are computer literate (have used a computer for at least 6 months)
  • understand how to use the Internet (have accessed the Internet on at least 6 occasions)
  • have access to a computer with a non-dial-up Internet connection in a private location (home)
  • are mentally capable of informed consent
  • are reachable by telephone
  • have no pre-existing medical condition(s) or severe diabetes related complications that would interfere with study participation (i.e., physical activity) or measures (e.g., renal failure, Stage III hypertension, severe orthopedic conditions or joint replacement scheduled within 6 months, paralysis, bleeding disorders, cancer, or receipt of pharmacologic doses of anti-coagulant medications [warfarin])
  • are able to travel to Duke University Medical Center (DUMC) for follow-up appointments.

Exclusion Criteria:

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01186965

United States, North Carolina
Duke University Medical Center
Durham, North Carolina, United States, 27710
Sponsors and Collaborators
Duke University
Principal Investigator: Constance M Johnson, PhD Duke University School of Nursing

Responsible Party: Duke University
ClinicalTrials.gov Identifier: NCT01186965     History of Changes
Other Study ID Numbers: Pro00022132
R21LM010727-02 ( U.S. NIH Grant/Contract )
First Posted: August 23, 2010    Key Record Dates
Last Update Posted: March 6, 2015
Last Verified: March 2015

Keywords provided by Duke University:
Second Life
virtual community
diabetes education
diabetes support group

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases